| Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion SM Devine, AM Bartholomew, N Mahmud, M Nelson, S Patil, W Hardy, ... Experimental hematology 29 (2), 244-255, 2001 | 638 | 2001 |
| Modification of hematopoietic stem cell fate by 5aza 2′ deoxycytidine and trichostatin A M Milhem, N Mahmud, D Lavelle, H Araki, J DeSimone, Y Saunthararajah, ... Blood 103 (11), 4102-4110, 2004 | 253 | 2004 |
| Human CD34+ stem cells express the hiwigene, a human homologue of the Drosophila genepiwi AK Sharma, MC Nelson, JE Brandt, M Wessman, N Mahmud, KP Weller, ... Blood, The Journal of the American Society of Hematology 97 (2), 426-434, 2001 | 249 | 2001 |
| Pivotal contributions of megakaryocytes to the biology of idiopathic myelofibrosis SO Ciurea, D Merchant, N Mahmud, T Ishii, Y Zhao, W Hu, E Bruno, ... Blood, The Journal of the American Society of Hematology 110 (3), 986-993, 2007 | 234 | 2007 |
| Baboon Mesenchymal Stem Cells Can Be Genetically Modified to Secrete Human Erythropoietin In Vivo A Bartholomew, S Patil, A Mackay, M Nelson, D Buyaner, W Hardy, ... Human gene therapy 12 (12), 1527-1541, 2001 | 222 | 2001 |
| Activation of Rac1 and the p38 mitogen-activated protein kinase pathway in response to all-trans-retinoic acid Y Alsayed, S Uddin, N Mahmud, F Lekmine, DV Kalvakolanu, S Minucci, ... Journal of Biological Chemistry 276 (6), 4012-4019, 2001 | 220 | 2001 |
| Nonmyeloablative stem cell transplantation with alemtuzumab/low-dose irradiation to cure and improve the quality of life of adults with sickle cell disease SL Saraf, AL Oh, PR Patel, Y Jalundhwala, K Sweiss, M Koshy, ... Biology of Blood and Marrow Transplantation 22 (3), 441-448, 2016 | 136 | 2016 |
| The relative quiescence of hematopoietic stem cells in nonhuman primates N Mahmud, SM Devine, KP Weller, S Parmar, C Sturgeon, MC Nelson, ... Blood, The Journal of the American Society of Hematology 97 (10), 3061-3068, 2001 | 129 | 2001 |
| Expansion of human umbilical cord blood SCID-repopulating cells using chromatin-modifying agents H Araki, N Mahmud, M Milhem, R Nunez, M Xu, CA Beam, R Hoffman Experimental hematology 34 (2), 140-149, 2006 | 125 | 2006 |
| Chromatin-modifying agents permit human hematopoietic stem cells to undergo multiple cell divisions while retaining their repopulating potential H Araki, K Yoshinaga, P Boccuni, Y Zhao, R Hoffman, N Mahmud Blood 109 (8), 3570-3578, 2007 | 114 | 2007 |
| Expression of MDR1 gene in acute leukemia cells: association with CD7+ acute myeloblastic leukemia/acute lymphoblastic leukemia H Miwa, K Kita, K Nishii, N Morita, N Takakura, K Ohishi, N Mahmud, ... | 90 | 1993 |
| The constitutive mobilization of bone marrow-repopulating cells into the peripheral blood in idiopathic myelofibrosis M Xu, E Bruno, J Chao, H Ni, V Lindgren, R Nunez, N Mahmud, G Finazzi, ... Blood 105 (4), 1699-1705, 2005 | 83 | 2005 |
| Studies of the route of administration and role of conditioning with radiation on unrelated allogeneic mismatched mesenchymal stem cell engraftment in a nonhuman primate model N Mahmud, W Pang, C Cobbs, P Alur, J Borneman, R Dodds, ... Experimental hematology 32 (5), 494-501, 2004 | 81 | 2004 |
| Induction of specific T cell immunity in patients with prostate cancer by vaccination with PSA146–154 peptide S Perambakam, S Hallmeyer, S Reddy, N Mahmud, L Bressler, ... Cancer Immunology, Immunotherapy 55, 1033-1042, 2006 | 80 | 2006 |
| Accelerated cell-cycling of hematopoietic progenitors by the flt3 ligand that is modulated by transforming growth factor-beta K Ohishi, N Katayama, R Itoh, N Mahmud, H Miwa, K Kita, N Minami, ... | 61 | 1996 |
| Accelerated cell-cycling of hematopoietic progenitor cells by growth factors R Tanaka, N Katayama, K Ohishi, N Mahmud, R Itoh, Y Tanaka, ... | 59 | 1995 |
| Haploidentical peripheral blood stem cell transplantation demonstrates stable engraftment in adults with sickle cell disease SL Saraf, AL Oh, PR Patel, K Sweiss, M Koshy, S Campbell-Lee, ... Biology of Blood and Marrow Transplantation 24 (8), 1759-1765, 2018 | 56 | 2018 |
| Differential effects of epigenetic modifiers on the expansion and maintenance of human cord blood stem/progenitor cells N Mahmud, B Petro, S Baluchamy, X Li, S Taioli, D Lavelle, JG Quigley, ... Biology of Blood and Marrow Transplantation 20 (4), 480-489, 2014 | 55 | 2014 |
| Combination of linear accelerator–based intensity-modulated total marrow irradiation and myeloablative fludarabine/busulfan: A phase I study P Patel, B Aydogan, M Koshy, D Mahmud, A Oh, SL Saraf, JG Quigley, ... Biology of Blood and Marrow Transplantation 20 (12), 2034-2041, 2014 | 47 | 2014 |
| Fludarabine/iv BU conditioning regimen: myeloablative, reduced intensity or both? S Chunduri, LC Dobogai, D Peace, Y Saunthararajah, J Quigley, ... Bone marrow transplantation 41 (11), 935-940, 2008 | 41 | 2008 |
